Highest priority programs – BEAM-101 and ESCAPE for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency – expected to provide foundation for meaningful value creation Company to ...
SOUTH PLAINFIELD, N.J., Sept. 28, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) announced today further strategic prioritization and associated workforce reduction. The portfolio prioritization ...
21st April 2026: This manual has been updated to include further details on how NICE will prioritise topics to reflect the latest system priorities and new national policies. These updates include: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results